Sep 12, 2019 / 12:30PM GMT
Operator
Good afternoon, and welcome to the Adverum Biotechnologies Conference Call and Webcast. (Operator Instructions) As a reminder, this conference call is being recorded.
I would now like to hand the call over to Myesha Lacy, Vice President of Investor Relations and Corporate Communications of Adverum. Please go ahead.
Myesha Lacy - Adverum Biotechnologies, Inc. - VP of IR & Corporate Communications
Thank you, operator, and welcome, everyone, to our conference call to discuss the OPTIC Phase I clinical data from the first 24 weeks of the first cohort of patients treated with ADVM-022 for wet AMD. These data were presented this morning by Dr. Kiss during the podium presentation at the Retina Society 2019 Annual Meeting, being held in London. A copy of the presentation that Dr. Kiss will review on today's call will be available on the Events and Presentations page of the Investor Relations section of our corporate website at www.adverum.com. The press release we issued this morning at the
Adverum Biotechnologies Inc to Review Data Presented at Retina Society 2019 Conference Call Transcript
Sep 12, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers